SARM

Patent Pending Selective androgen receptor modulators or SARMs are a novel class of androgen receptor ligands. (The name follows the terminology currently used for similar molecules targeting the estrogen receptor, "selective estrogen receptor modulators," such as Tamoxifen.) They are intended to have the same kind of effects as androgenic drugs like anabolic steroids but be much more selective in their action,[1] allowing them to be used for many more clinical indications than the relatively limited legitimate uses that anabolic steroids are currently approved for.